Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000005338 | SCV001587497 | pathogenic | Giant axonal neuropathy 1 | 2022-07-18 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 5035). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects GAN function (PMID: 24758703). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This missense change has been observed in individual(s) with a mild form of giant axonal neuropathy (PMID: 11053687, 11062483). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs119485092, gnomAD 0.0009%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 138 of the GAN protein (p.Arg138His). |
OMIM | RCV000005338 | SCV000025516 | pathogenic | Giant axonal neuropathy 1 | 2000-12-01 | no assertion criteria provided | literature only | |
Inherited Neuropathy Consortium | RCV000005338 | SCV000929143 | uncertain significance | Giant axonal neuropathy 1 | no assertion criteria provided | literature only | ||
Inherited Neuropathy Consortium Ii, |
RCV000005338 | SCV004174514 | uncertain significance | Giant axonal neuropathy 1 | 2016-01-06 | no assertion criteria provided | literature only |